GTS Securities’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

GTS Securities’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,500	Closed	-$332	–	4214
2023 Q2	$332	Buy	+25,500	New	+$788	﹤0.01%	1209

GTS Securities's GRNAW Position: Q3 2023 in Review

GTS Securities sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 25,500 shares — an estimated $332 sold.

GTS Securities first reported a position in GRNAW in Q2 2023 and held it in 1 quarter. The position peaked at $332 in Q2 2023. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

GTS Securities reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
GTS Securities sold 25,500 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $332.
GTS Securities first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q2 2023 and held it in 1 quarter.
GTS Securities's GreenLight Biosciences Holdings, PBC Warrant position peaked at $332 in Q2 2023.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on GTS Securities's 13F filing for Q3 2023, filed 15 Nov 2023.